Congratulations to Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New
Orleans, on publishing his findings on a new target drug to fight triple-negative
breast cancer. Dr. Alahari’s research has been featured in several media outlets.
Dr. Alahari was a past LA CaTS Pilot Grant Awardee from 2012-2013. His project focus
was on “MicroRNAs as Prognostic Markers of Breast Cancer”. On behalf of the LA CaTS Center, we commend you on your success in this important
area of chronic disease research affecting our state.
Read more on Dr. Alahari’s research below:
New drug target for triple-negative breast cancer (Science Daily)
LSU Health Research Finds New Drug Target For Triple-Negative Breast Cancer (L'Observateur)
Novel drug target for triple-negative breast cancer discovered (News Medical)